Clinical Trial Update: Multiple Oral Dose Safety, Tolerability And Pharmacokinetic Study Of PF-04287881 In Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, and pharmacokinetics of PF-04287881 given in multiple oral doses to healthy adult volunteers, in a trial investiga…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infection

Drugs mentioned

• PF-04287881

Snippet

Sponsor: Pfizer | Conditions: Respiratory Tract Infections | Phase 1 | Status: COMPLETED